Anlotinib combined with benmelstobart as a chemo-free first-line treatment in advanced esophageal squamous cell carcinoma: an exploratory multicenter, single-arm phase II clinical trial. - Meng, Xiangrui; Yang, Xiuli; Hong, Yonggui; Wang, Wenkang; Zhang, Zhiye; Xia, Jin; Chen, Yunfang; Zhou, Yue; Lu, Taiying; Song, Min; Shan, Zhengzheng; Wu, Tao; et al. (Molecular Cancer, 2025)